
Legislative Mandate: Section 22C(1)(b) of MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 as amended and Regulation 23.
The Pharma Licencing sub-unit is responsible for issuing to a manufacturer, wholesaler or distributor of a medicine or scheduled substance, a licence to manufacture, import, export, act as a wholesaler of or distribute, as the case may be, such medicine and/or scheduled substance, upon such conditions as to the application of such acceptable quality assurance principles and good manufacturing and/or distribution practices as the Authority may determine.
For facilities handling Medical Devices or Complementary Medicines, refer to the appropriate webpages.
Submission for the following licence applications only:
Completed application forms with the following supporting documents:
Applicants to submit a zipped file.
Fees information below:

Dear Stakeholder,
The Pharma Licensing dedicated inbox will be amended from gmplicensing@sahpra.org.za to pharmalicensing@sahpra.org.za from 1st March 2026. Applicants are urged to forward their applications to the new dedicated email address.
The Pharma Licensing unit of SAHPRA emphasises that any critical changes (refer Regulation23(7) of the Medicines Act) to the pharmaceutical facility be approved by SAHPRA prior to implementation: Guideline on how to amend a current licence.
Additionally, licence holders are reminded to apply for the renewal of the licence every 5 years, at least 180 days before the expiry of the existing licence.
Regards,
Pharma Licensing Unit